Search results
For women with osteoporosis who are at least 65 years of age and have a high risk for fracture, treatment decisions should be individualized; risk versus benefit, patient preferences, fracture-risk profile, and costs should be assessed to determine if osteoporotic treatment is warranted.
20 maj 2020 · Osteoporosis occurs when the body loses too much bone mass, or doesn’t build new bone fast enough, increasing the risk of fractures. Some medications prescribed to promote bone health and bone density can cause side effects that may disturb sleep and promote fatigue.
12 mar 2022 · Sclerostin blockade both stimulates bone formation and inhibits bone resorption. The inhibition of bone resorption is achieved via effects on osteoprotegerin levels. Romosozumab, a humanised monoclonal anti-sclerostin antibody, is available for osteoporosis treatment.
28 kwi 2022 · Untreated osteoporosis can lead to a vicious cycle of recurrent fracture(s), often resulting in disability and premature death. In appropriate patients, treatment with effective antifracture medication prevents fractures and improves outcomes.
28 sie 2024 · Bisphosphonates are often the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel, Atelvia), a weekly or monthly pill. Ibandronate, a monthly pill or quarterly intravenous (IV) infusion. Zoledronic acid (Reclast), an annual IV infusion.
18 lip 2023 · Osteoporosis requires long-term prevention or therapy based on specific bone medication and/or general measures; specific therapy principles encompass antiresorptive or osteoanabolic approaches...
In appropriate patients, treatment with effective antifracture medication prevents fractures and improves outcomes. Primary care providers and medical specialists are critical gatekeepers who can identify fractures and initiate proven osteoporosis interventions.
